Search
Milestone Pharmaceuticals Inc
MISTAdd to Watchlist
1.320USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
155.49MMarket Cap
LossP/E TTM
Milestone Pharmaceuticals Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
1.55M
--
EPS(YoY)
-0.75
-12.64%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Milestone Pharmaceuticals Inc?
According to Milestone Pharmaceuticals Inc's FY2025 earnings report, its current assets were 111.92M, with a year-on-year change of 51.40.
What are the total assets of Milestone Pharmaceuticals Inc?
According to Milestone Pharmaceuticals Inc's FY2025 earnings report, its total assets of Milestone Pharmaceuticals Inc were 113.56M, with a year-on-year change of 50.41.
What are the total liabilities of Milestone Pharmaceuticals Inc?
According to Milestone Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Milestone Pharmaceuticals Inc were 71.79M, with a year-on-year change of 15.14.
What is the total equity of Milestone Pharmaceuticals Inc?
According to Milestone Pharmaceuticals Inc's FY2025 earnings report, its total equity of Milestone Pharmaceuticals Inc was 41.77M, with a year-on-year change of 217.71.
What is the net investment of Milestone Pharmaceuticals Inc?
According to Milestone Pharmaceuticals Inc's FY2025 earnings report, its net investment of Milestone Pharmaceuticals Inc was 11.25M, with a year-on-year change of 35.77.
What is the net financing of Milestone Pharmaceuticals Inc?
According to Milestone Pharmaceuticals Inc's FY2025 earnings report, its net financing of Milestone Pharmaceuticals Inc was 85.53M, with a year-on-year change of 166.28.
What is the Earnings Per Share (EPS) of Milestone Pharmaceuticals Inc?
According to Milestone Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.75, with a year-on-year change of -12.64.
What is the debt-to-asset ratio of Milestone Pharmaceuticals Inc?
According to Milestone Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 50.36, with a year-on-year change of -28.73.
What is the Return on Equity (ROE) of Milestone Pharmaceuticals Inc?
According to Milestone Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -229.65, with a year-on-year change of 17.26.
What is the Return on Assets (ROA) of Milestone Pharmaceuticals Inc?
According to Milestone Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -66.71, with a year-on-year change of -21.08.
What is the operating profit of Milestone Pharmaceuticals Inc?
According to Milestone Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -62.48M, with a year-on-year change of -47.51.